T1	Participants 97 106	in adults
T2	Participants 609 655	101 eligible cases (bestatin: 48, control: 53)
T3	Participants 905 950	15-49 yr age group, in the 50-65 yr age group
T4	Participants 1119 1138	in elderly patients
